Eflornithine

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma

Chemoprevention of Gastric Carcinogenesis

Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer

Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer

Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer

Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2

Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

Eflornithine in Treating Patients With Bladder Cancer

Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy

Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus